Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pfizer (PFE) drops takeover plans for AstraZeneca (AZN)

Canadian Press, The Canadian Press
1 Comment| May 26, 2014

{{labelSign}}  Favorites
{{errorMessage}}

NEW YORK _ Pfizer (NYSE:PFE, Stock Forum) says it does not intend to make a takeover offer for British drugmaker AstraZeneca (NYSE:AZN, Stock Forum).

The announcement Monday comes a week after AstraZeneca's board rejected a proposed $119-billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue.

Pfizer Chairman and CEO Ian Read says the company's final proposal represented full value for AstraZeneca.

Pfizer, the maker of Lipitor and Viagra, has been courting No. 8 AstraZeneca since January, saying their businesses would be stronger together.

Pfizer had been waiting for AstraZeneca to engage in merger talks by a Monday deadline.

Pfizer has previously said it would not make a hostile takeover bid directly to AstraZeneca's stockholders.



{{labelSign}}  Favorites
{{errorMessage}}

Related News